Nurse helping VYEPTI® patient with IV bag.

Why IV Treatment

Migraine prevention
delivered differently

Actor portrayal

Discover intravenous (IV) infusion

""

Just four 30-minute IV infusions a year (every 3 months) given by a healthcare provider.

""

100% of the medication is delivered into your bloodstream, so it can get right to work.

""

86% of people receiving VYEPTI agreed that their infusion experience was positive

Based on survey responses from 713 people enrolled in the VYEPTI GO program through December 2023.

Individual experiences may vary. Survey responses collected between 4/1/21 and 12/15/23.

Learn more about the VYEPTI IV infusion

Take a closer look at what you can expect during and after your VYEPTI IV infusion experience, including how quickly you can get back to your day. And that's not all—learn about the results with VYEPTI, such as how fast the medication can start working and how long it can last.

Have questions about the VYEPTI IV infusion? Get answers from nurses ready to help.

""

“My infusion experience has been positive. I go to an infusion center. The infusion is just 30 minutes. I lay back and relax. They come and check on me and I’m done.”


June, VYEPTI patient

The infusion will take about 30 minutes, but your total appointment time may vary.
June was compensated for her time.

VYEPTI® patient ambassador June smiling.

Swipe for more

Dosing for VYEPTI and other preventive migraine treatment options

VYEPTI is a preventive treatment for migraine that’s delivered differently. Check out how often these preventive migraine treatments are given.

This is not a comparison of how well each treatment works or how safe they may be.

IV infusion for migraine
VYEPTI® (eptinezumab-jjmr)
4x a year
One 30-minute infusion administered by a healthcare provider 4x a year
One 30-minute infusion administered by a healthcare provider 4x a year
Migraine injections
Aimovig® (erenumab-aooe)
12x a year
One self-injection 1x a month
One self-injection 1x a month
AJOVY® (fremanezumab-vfrm)
12x or 4x a year
One self-injection 1x a month or 3 self-injections, 4x a year
One self-injection 1x a month or 3 self-injections, 4x a year
BOTOX® (onabotulinumtoxinA)
4x a year
31 injections at each treatment visit, 4x a year
31 injections at each treatment visit, 4x a year
Emgality® (galcanezumab-gnlm)
12x a year
One self-injection 1x a month (after initial loading dose*)
One self-injection 1x a month (after initial loading dose*)
Migraine pills
Nurtec® ODT (rimegepant)
182x a year
One pill every other day
One pill every other day
QULIPTA® (atogepant)
365x a year
One pill 1x a day
One pill 1x a day

*The first dose is a loading dose and may be given as 1 or 2 injections.The above is not a complete list of preventive treatments of migraine in adults. The comparison pertains only to differences in dosing and administration and should not be considered a comparison of efficacy or safety. Trademarks are the property of their respective owners. Please see each product's full Prescribing Information for additional information, including indication, dosing, and safety.

Take a look

Say yep to more migraine-free days

Migraine prevention that's proven to last 3 months in clinical studies.

How to start the conversation

Ask your doctor if VYEPTI could be a yep for you

Before your next appointment, create your own Doctor Discussion Guide with personalized responses specific to your concerns and experience with migraine.

IMPORTANT SAFETY INFORMATION
AND APPROVED USE

Do not receive VYEPTI if you have a known allergy to eptinezumab-jjmr or its ingredients.

APPROVED USE

VYEPTI is a prescription medicine used for the preventive treatment of migraine in adults.

VYEPTI may cause allergic reactions. Call your healthcare provider or get emergency medical help right away if you have any symptoms of an allergic reaction: rash; swelling of your face, lips, tongue, or throat; if you have trouble breathing; hives; or redness in your face.

Before starting VYEPTI, tell your healthcare provider about all your medical conditions, including if you are pregnant or plan to become pregnant, or you are breastfeeding or plan to breastfeed.

Tell your healthcare provider about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.

The most common side effects of VYEPTI include stuffy nose and scratchy throat, and allergic reactions.

These are not all the possible side effects of VYEPTI. Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

For more information, please see the Prescribing Information and Patient Information.

APPROVED USE

VYEPTI is a prescription medicine used for the preventive treatment of migraine in adults.

IMPORTANT SAFETY INFORMATION

Do not receive VYEPTI if you have a known allergy to eptinezumab-jjmr or its ingredients.

VYEPTI may cause allergic reactions. Call your healthcare provider or get emergency medical help right away if you have any symptoms of an allergic reaction: rash; swelling of your face, lips, tongue, or throat; if you have trouble breathing; hives; or redness in your face.

Before starting VYEPTI, tell your healthcare provider about all your medical conditions, including if you are pregnant or plan to become pregnant, or you are breastfeeding or plan to breastfeed.

Tell your healthcare provider about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.

The most common side effects of VYEPTI include stuffy nose and scratchy throat, and allergic reactions.

These are not all the possible side effects of VYEPTI. Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

For more information, please see the Prescribing Information and Patient Information.